Korro Bio, Inc. (KRRO)
NASDAQ·Healthcare·Biotechnology
$12.76
-0.66%
Mkt Cap $115.83M
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$20.29
Range $10.00 – $30.00
Implied Upside
+59.1%
Consensus $20.29 vs current $12.76
NASDAQ·Healthcare·Biotechnology
$12.76
-0.66%
Mkt Cap $115.83M
No recent rating data.
Price Target (14 analysts)
$20.29
Range $10.00 – $30.00
+59.1%
Consensus $20.29 vs current $12.76